Format

Send to

Choose Destination
Circulation. 2004 Nov 23;110(21):3378-83.

In vivo tracking of stem cells for clinical trials in cardiovascular disease.

Author information

1
Division of Hematology/Oncology, Department of Radiology, and Molecular Imaging Center, Beth Israel Deaconess Medical Center, 330 Brookline Ave, SL-B05, Boston, Mass 02215, USA. jfrangio@bidmc.harvard.edu

Abstract

Various stem cells hold promise for the treatment of human cardiovascular disease. Regardless of stem cell origin, future clinical trials will require that the location and number of such cells be tracked in vivo, over long periods of time. The problem of tracking small numbers of cells in the body is a difficult one, and an optimal solution does not yet exist. We review the many contrast agents and detectors that have been proposed for stem cell tracking during clinical trials, define the characteristics of an ideal imaging technology, and suggest future directions for research.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center